#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Idiopathic inflammatory myopathy Rheumatoid arthritis Gastrointestinal cancer metastatic Post transplant lymphoproliferative disorder Haemophilia Anti-HLA antibody test positive Trigeminal neuralgia Intracranial calcification Langerhans cell sarcoma Intracranial germ cell tumour Small intestine neuroendocrine tumour Cerebral arteriovenous malformation haemorrhagic Lymphoma Astrocytoma More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Treatment Kearns-Sayre syndrome – Life with Disease Pemphigoid – Diagnostics Mantle cell lymphoma stage II – Diagnostics Leiomyosarcoma metastatic Ewing’s sarcoma recurrent – Treatment Krabbe’s disease – Diagnostics Marginal zone lymphoma – Life with Disease Shprintzen-Goldberg syndrome – Diagnostics Primary hyperoxaluria – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rasagiline 12 Grass Pollen Mixture Bosutinib Tirzepatide SGT-003 Caffeine Icatibant SEPOFARSEN Dexamethasone Acetate ZUNIBERGENE ROCPARVOVEC Reparixin Sitagliptin Paracetamol Ph. Eur. Azd8421 Basimglurant Bupivacaine Hydrochloride Ranitidine Hydrochloride Cefepime Hydrochloride XELAFASLATIDE Star-0215 More therapies…

    Learn about Your Condition

    Infective uveitis Oral lichen planus Rhabdoid tumour Immunosuppression Meningioma malignant Abortion threatened Alpha-1 antitrypsin deficiency Mantle cell lymphoma stage III Diabetic nephropathy Angiosarcoma metastatic Viral myocarditis Axial spondyloarthritis Chondrosarcoma Nasopharyngeal cancer Neurofibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Specjalistyczna Praktyka Lekarska Slawomir Mandziuk…

Specjalistyczna Praktyka Lekarska Slawomir Mandziuk

ul. Chodzki 17/2, Lublin, 20-093, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rbl005.3
    • Rbl007.2
    • Rbl012.2
    Germany Poland Spain

  • Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Ivonescimab
    • Paclitaxel
    France Germany Greece Ireland Italy Poland +1

  • Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Lurbinectedin
    • Irinotecan
    • Topotecan
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Adagrasib
    • Docetaxel
    Austria Belgium Czechia France Germany Greece +8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!